Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 440 participants.

Also called NCT02007837

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 440 participants (planned count) (from the registry)
Sponsor
  • UMC Utrecht Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02007837
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Ghana (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02007837. Randomized; quadruple masking; primary purpose prevention. Start 2018-01 (registry gives no type); primary completion 2018-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial
Acronym
4P
Condition
Pregnancy Induced Hypertension
Intervention (Drug)
Combined aspirin and multinutrient supplement
Intervention (Other)
Daily text reminder text messages
Lead sponsor
UMC Utrecht (class: other)
Collaborator
Ghana Health Services (class: other government)
Collaborator
University of Ghana (class: other)

Record details

Record id
cardio:ct-nct02007837
Content hash
87392c67721e5e73b61a8f9b8ecdeb743fa63c168657ed7ecfa524e7d1496885